These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 19169055

  • 41. High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture.
    Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Palummeri E, Pioli G.
    J Endocrinol Invest; 2006 Oct; 29(9):809-13. PubMed ID: 17114912
    [Abstract] [Full Text] [Related]

  • 42. Vitamin D Status and Indices of Mineral Homeostasis in the Population: Differences Between 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D.
    Cirillo M, Bilancio G, Guarino E, Cavallo P, Lombardi C, Costanzo S, De Curtis A, Di Castelnuovo A, Iacoviello L.
    Nutrients; 2019 Aug 01; 11(8):. PubMed ID: 31374914
    [Abstract] [Full Text] [Related]

  • 43. High parathyroid hormone predicts exacerbations in COPD patients with hypovitaminosis D.
    Amado CA, Muñoz P, García-Unzueta M, Agüero J, Tello S, Fueyo P, Vega C, Lavín BA, Guerra RA, Casanova C.
    Respir Med; 2021 Jun 01; 182():106416. PubMed ID: 33894440
    [Abstract] [Full Text] [Related]

  • 44. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women.
    Bhattoa HP, Bettembuk P, Ganacharya S, Balogh A.
    Osteoporos Int; 2004 Jun 01; 15(6):447-51. PubMed ID: 15205715
    [Abstract] [Full Text] [Related]

  • 45. Relationships of serum 25-hydroxyvitamin D, ionized calcium and parathyroid hormone after obesity surgery.
    Hewitt S, Aasheim ET, Søvik TT, Jahnsen J, Kristinsson J, Eriksen EF, Mala T.
    Clin Endocrinol (Oxf); 2018 Mar 01; 88(3):372-379. PubMed ID: 29235126
    [Abstract] [Full Text] [Related]

  • 46. Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis.
    Braun-Moscovici Y, Furst DE, Markovits D, Rozin A, Clements PJ, Nahir AM, Balbir-Gurman A.
    J Rheumatol; 2008 Nov 01; 35(11):2201-5. PubMed ID: 18843781
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.
    Jungert A, Neuhäuser-Berthold M.
    Nutr Res; 2013 Aug 01; 33(8):661-7. PubMed ID: 23890356
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
    Elias RM, Moysés RMA.
    Int Urol Nephrol; 2017 Oct 01; 49(10):1815-1821. PubMed ID: 28695313
    [Abstract] [Full Text] [Related]

  • 54. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
    Lomonte C, Antonelli M, Vernaglione L, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Basile C.
    J Nephrol; 2005 Oct 01; 18(1):96-101. PubMed ID: 15772930
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study.
    Souberbielle JC, Massart C, Brailly-Tabard S, Cavalier E, Chanson P.
    Endocrine; 2016 Aug 01; 53(2):543-50. PubMed ID: 27106800
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Defining vitamin D status by secondary hyperparathyroidism in the U.S. population.
    Ginde AA, Wolfe P, Camargo CA, Schwartz RS.
    J Endocrinol Invest; 2012 Jan 01; 35(1):42-8. PubMed ID: 21606669
    [Abstract] [Full Text] [Related]

  • 59. Lower total 25-hydroxyvitamin D but no difference in calculated or measured free 25-hydroxyvitamin D serum levels in patients with primary hyperparathyroidism.
    Meng L, Su C, Shapses SA, Al-Dayyeni A, He Y, Wang X.
    J Steroid Biochem Mol Biol; 2020 May 01; 199():105616. PubMed ID: 32027935
    [Abstract] [Full Text] [Related]

  • 60. Low serum 25-hydroxyvitamin D levels and secondary hyperparathyroidism in Fontan patients.
    Holler F, Hannes T, Germund I, Emmel M, Hoyer-Kuhn H, Khalil M, Sreeram N, Udink Ten Cate FE.
    Cardiol Young; 2016 Jun 01; 26(5):876-84. PubMed ID: 26279316
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.